All In Biotech

Free tool

FAERS Monitor: Repatha

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125522 or its brand name (Repatha, Evolocumab). Reports on generic versions are filed under their own applications.

Reports

165,049

Serious

28,672

17% of reports

Hospitalization

9,006

Death reported

2,144

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • device difficult to use33,254
  • drug dose omission by device24,856
  • wrong technique in product usage process22,690
  • accidental exposure to product17,173
  • injection site pain11,254
  • product storage error6,709
  • back pain5,658
  • myalgia5,484
  • injection site bruising4,954
  • drug dose omission4,929
  • device use error4,408
  • fatigue4,161
  • arthralgia4,143
  • injection site haemorrhage4,136
  • off label use3,997

Reports by year received

View as table
YearReports
20081
20101
20121
201413
2015801
20166,377
201720,201
201828,249
20199,722
20208,999
202110,476
202212,351
202324,562
202425,531
20257,912
20269,852

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,889,110 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
device difficult to useSignal33,254127.5125.72,085,871
drug dose omission by deviceSignal24,85658.857.9967,457
accidental exposure to productSignal17,17325.324.9335,384
device use errorSignal4,40818.417.863,301
wrong technique in product usage processSignal22,69015.915.7284,924
product storage errorSignal6,70910.510.253,422
injection site bruisingSignal4,9548.48.130,266
injection site haemorrhageSignal4,1366.96.719,874
injection site painSignal11,2544.84.733,255
myalgiaSignal5,4844.24.113,113
drug dose omissionSignal4,9293.93.810,327
back painSignal5,6583.23.18,219
arthralgia4,1431.31.2244
fatigue4,1610.70.7650
off label use3,9970.60.61,264

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.